Dr. Roberto Herrera III, DO

Dr. Herrera practices at Community Hospital North in Indianapolis, Indiana, part of Community Health Network.

Dr. Herrera's NPI, 1174812242, was assigned on March 29, 2011. Dr. Herrera graduated from Philadelphia College of Osteopathic Medicine in 2011. Dr. Herrera holds Indiana license 01087778A.

Dr. Herrera's primary practice is Community Hospital North, at 7150 Clearvista Dr, Indianapolis, IN 46256 in Marion County. The practice phone is (317) 621-5335.

Dr. Herrera's primary practice is Community Hospital North in Indianapolis, Indiana, part of Community Health Network. Dr. Herrera is also affiliated with Community Hospital East. The medical group on file is Community Physician Network. Dmand AI also links Dr. Herrera to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Herrera practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Herrera's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Herrera is board certified in internal medicine by the American Board of Internal Medicine. Dr. Herrera is licensed in Indiana.

CMS data shows 856 Medicare services from Dr. Herrera across 7 procedure codes in 2024, for 319 Medicare patients. Medicare paid $58,292 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 319 Medicare patients who saw Dr. Herrera in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Herrera's median patient age at 72, with 51% women.

In 2024, Dr. Herrera wrote 147 Medicare Part D claims for 79 patients. 95% of them were for generic drugs. CMS names the drug for 24 of them, across 2 drugs with 11 or more claims each, at $190 in total drug cost. In 2023, CMS named 54 claims across 3 drugs.

Dr. Herrera accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Herrera, published from 2021 to 2024. 2023 was the busiest year, with 3. The most frequent topics are Brachytherapy, Brain Neoplasms and Cesium Radioisotopes. Dr. Herrera has published most often in Brachytherapy. Dr. Herrera's most frequent co-authors are Michael David Chuong, MD, Rupesh Rajesh Kotecha, MD and Adeel Kaiser, MD.

CMS Open Payments shows 4 general payments to Dr. Herrera from 2 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $113.

Dr. Herrera graduated from Philadelphia College of Osteopathic Medicine in 2011.